Konrad Aden

Konrad Aden is a Professor at Kiel University and a senior physician at the Department of Internal Medicine I, University Medical Center Schleswig-Holstein (UKSH). He leads the Junior Research Group for Immunometabolism of Intestinal Inflammation and Systems Immunology at the Institute of Clinical Molecular Biology (IKMB), focusing on translating findings from clinical research and basic science into innovative IBD diagnostics and therapies.

• Key roles: Principal Investigator (Project 7), BMBF Juniorverbund Try-IBD coordinator
• Research areas: Immune-metabolic crosstalk in IBD, microbiome therapeutics, tryptophan and serine metabolism, systems immunology

His publications address metabolomic signatures in IBD, microbial interactions in chronic inflammation, and immune signaling pathways like cGAS-STING and JAK-STAT. Awards include the Else Kröner Clinician Scientist Professorship. He collaborates extensively with working groups at IKMB and employs preclinical models (organoids, DSS colitis) alongside clinical biobanks for translational research.